PET-CT/MR Center, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Molecular Imaging Center, Renmin Hospital of Wuhan University, Wuhan, 430060, Hubei, China.
Curr Microbiol. 2021 May;78(5):1718-1729. doi: 10.1007/s00284-021-02413-z. Epub 2021 Apr 13.
An ongoing global outbreak of coronavirus disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2; previously temporarily named 2019-nCoV) was reported in Wuhan, China at the end of 2019. SARS-CoV-2 has become a pandemic and a major public health concern. As of 18 January 2021, the virus has spread all over the world, resulting in over 99,026 cases in China and more than 95 million cases in another 216 countries. After three months of efforts, Chinese authorities have managed to control the outbreak by implementing aggressive and effective measures; by striking contrast, the number of confirmed patients outside China is still rapidly climbing following an exponential growth trend, especially in some European and American countries. To date, no specific therapeutic drugs still exist for COVID-19. Therefore, it is of utmost importance to understand the updated comprehensive summary regarding COVID-19, in the hopes of providing a reference for the intervention and prevention of the COVID-19 epidemic for public health authorities and healthcare workers around the world.
自 2019 年底中国武汉报告了由严重急性呼吸系统综合征冠状病毒 2(SARS-CoV-2;之前暂时命名为 2019-nCoV)引起的持续全球 2019 年冠状病毒病(COVID-19)爆发以来,SARS-CoV-2 已成为一种大流行病和主要的公共卫生关注点。截至 2021 年 1 月 18 日,该病毒已在全球范围内传播,在中国造成超过 99026 例病例,在另外 216 个国家造成超过 9500 万例病例。经过三个月的努力,中国当局通过实施积极有效的措施成功控制了疫情;相比之下,中国境外的确诊患者数量仍呈指数级增长趋势迅速攀升,尤其是在一些欧美国家。迄今为止,针对 COVID-19 仍然没有特定的治疗药物。因此,了解有关 COVID-19 的最新综合摘要非常重要,希望为全球公共卫生当局和医护人员提供干预和预防 COVID-19 疫情的参考。